# A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

> **NCT01228747** · PHASE3 · COMPLETED · sponsor: **UCB Japan Co. Ltd.** · enrollment: 361 (actual)

## Conditions studied

- Epilepsy
- Generalized Tonic-Clonic Seizures

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01228747
- **Lead sponsor:** UCB Japan Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-05
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228747, "A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01228747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*